Skip to main content
. 2020 May 4;94(10):e02123-19. doi: 10.1128/JVI.02123-19

TABLE 1.

Results from treating IRAK pathway knockout cells with the MYD88 ST2825 dimerization inhibitor

Cell line EC50 value (μM)a
SD
Replicate 1 Replicate 2 Replicate 3 Avg
BCBL-1 WT 4.3 7.1 8.8 6.7 2.2
ΔIRAK4.1 9.3 3.3 4.9 5.8 3.1
ΔIRAK4.2 4.9 5.4 18 9.3 7.3
ΔIRAK1.1 29 2.3 5.1 12 14
ΔIRAK2.2 16 2.6 5.4 8.0 7.0
ΔMYD88.1 3.6 3.5 8.3 5.1 2.8
ΔMYD88.2 3.6 2.6 7.9 4.7 2.8
a

Three biological replicates, each the average from 4 technical replicates.